In ovarian cancer, antibodies against any of the MAGE family antigens (including MAGE-A1, MAGE-A4, MAGE-A3 and MAGE-A10) were correlated with a lower survival rate [25]. This evidence concerns the gene MAGEA3 and ovarian carcinoma.